Wenshu Yu, MD
Rheumatology · Provo, UTNPI 1073622288
Payments from drug & device makers
Across 1,079 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$2K
- Johnson & Johnson$2K
- Novartis$2K
- UCB, Inc.$1K
- Pfizer$943
- plus $6K from 27 others
What the payments were for
- Consulting fees$500%
- Food & beverage$16,67698%
- Education$3492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 272 | $3,820 |
| AbbVie | 113 | $2,010 |
| Johnson & Johnson(2 entities) | 76 | $1,723 |
| Novartis | 76 | $1,514 |
| UCB, Inc. | 74 | $1,483 |
| Pfizer | 159 | $943 |
| Mallinckrodt Hospital Products Inc. | 38 | $784 |
| AstraZeneca | 36 | $754 |
| GSK | 43 | $627 |
| Lilly USA, LLC | 33 | $575 |
| Genentech USA, Inc. | 26 | $552 |
| ANI Pharmaceuticals, Inc. | 22 | $348 |
| E.r. Squibb & Sons, L.L.C. | 23 | $270 |
| Organon | 18 | $255 |
| Sanofi | 11 | $213 |
| Fresenius Kabi USA, LLC | 10 | $168 |
| Boehringer Ingelheim | 7 | $157 |
| Actelion Pharmaceuticals US, Inc. | 9 | $145 |
| Janssen Scientific Affairs, LLC | 1 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Radius Health, Inc. | 5 | $82 |
| Octapharma USA, Inc. | 3 | $69 |
| Sandoz | 3 | $67 |
| Sobi, Inc | 5 | $65 |
| Genentech, Inc. | 2 | $54 |
| Pacira Therapeutics, Inc. | 2 | $40 |
| Gilead | 2 | $37 |
| Mylan Institutional Inc. | 1 | $33 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Bioventus LLC | 1 | $16 |
| Qiagen, LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,075 in reported general payments places this provider in the 75th percentile of 52 rheumatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $104,142 |
| Hydroxychloroquine Sulfate | 146 | $4,491 |
| MethotrexateMethotrexate Sodium | 135 | $2,937 |
| Celecoxib | 51 | $2,237 |
| Leflunomide | 16 | $1,934 |
| Allopurinol | 31 | $1,504 |
| Diclofenac Sodium | 61 | $1,264 |
| Nabumetone | 11 | $858 |
| Prednisone | 98 | $833 |
| Colchicine | 20 | $756 |
| Pilocarpine Hcl | 16 | $553 |
| Meloxicam | 60 | $329 |
| Omeprazole | 17 | $219 |
| Gabapentin | 23 | $210 |
| Alendronate Sodium | 15 | $91 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Provo
- Michael DarleyProvo$13K
- James SteierProvo$2K
- Richard CallProvo$52
- Jessica WalshSlc$1.4M
- Catherine BakewellSalt Lake City$1.2M
- Brayden YellmanMurray$452K
- Grant CannonSalt Lake City$187K
- Shruti SanghviVineyard$63K
- Curry KoeningSalt Lake City$63K
- Carmen GotaSt. George$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.